Azenta Inc

NASDAQ AZTA

Download Data

Azenta Inc Market Capitalization on June 03, 2024: USD 2.75 B

Azenta Inc Market Capitalization is USD 2.75 B on June 03, 2024, a 7.57% change year over year. Market capitalization is a financial metric that represents the total value of a publicly traded company. It is calculated by multiplying the current share price of a company by the total number of outstanding shares. Market capitalization is used to assess the size and relative value of a company in the stock market. It provides investors with an idea of the company's overall worth and is often used as a basis for comparing companies within the same industry or sector. A higher market capitalization generally indicates a larger, more established company.
  • Azenta Inc 52-week high Market Capitalization is USD 3.87 B on February 02, 2024, which is 40.91% above the current Market Capitalization.
  • Azenta Inc 52-week low Market Capitalization is USD 2.45 B on October 30, 2023, which is -10.72% below the current Market Capitalization.
  • Azenta Inc average Market Capitalization for the last 52 weeks is USD 3.05 B.
NASDAQ: AZTA

Azenta Inc

CEO Dr. Stephen S. Schwartz
IPO Date Feb. 2, 1995
Location United States
Headquarters 15 Elizabeth Drive, Chelmsford, MA, United States, 01824
Employees 3,400
Sector Healthcare
Industry Medical instruments & supplies
Description

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Similar companies

AKYA

Akoya Biosciences Inc

NA

NA

ANGO

AngioDynamics Inc

NA

NA

HOLX

Hologic Inc

NA

NA

BDX

Becton Dickinson and Company

NA

NA

StockViz Staff

September 20, 2024

Any question? Send us an email